What is the test for anti double stranded DNA antibodies

Anti double stranded DNA antibodies are an important serological indicator used to assist in the diagnosis of systemic lupus erythematosus. This antibody test is mainly used to evaluate the disease activity of systemic lupus erythematosus, especially closely related to renal involvement.

1. Diagnosis of systemic lupus erythematosus:

Anti double stranded DNA antibodies are one of the highly specific biomarkers of systemic lupus erythematosus. When patients experience symptoms such as facial butterfly erythema, joint swelling and pain, recurrent fever, oral ulcers, etc., doctors usually recommend this examination. The positive result of this antibody has important reference value for the diagnosis of systemic lupus erythematosus, and also helps to distinguish systemic lupus erythematosus from other rheumatic and immune diseases such as rheumatoid arthritis and Sjogren's syndrome.

2. Monitoring disease activity:

The level of anti double stranded DNA antibodies is positively correlated with the degree of disease activity in systemic lupus erythematosus. During the active phase of the disease, especially when active lupus nephritis occurs, the antibody titer usually increases significantly. By regularly reviewing anti double stranded DNA antibodies, doctors can evaluate treatment effectiveness, determine whether the condition is in a stable or active phase, and adjust treatment plans in a timely manner, such as whether to increase the use of glucocorticoids or immunosuppressants.

3. Assessing the risk of renal involvement:

Systemic lupus erythematosus patients with positive anti double stranded DNA antibodies and high titers have a significantly increased risk of developing lupus nephritis. Lupus nephritis is a common and serious complication of systemic lupus erythematosus, which can manifest as symptoms such as proteinuria, hematuria, edema, and hypertension. This antibody test can help detect early signs of kidney involvement, guide doctors to perform further examinations such as kidney biopsy, and develop targeted kidney protection treatment measures.

4. Auxiliary prognostic assessment: The sustained high or repeated elevation of

anti double stranded DNA antibodies usually indicates poor disease control, high risk of recurrence, and may have a relatively poor prognosis. On the contrary, if the antibody titer decreases or turns negative after effective treatment, it often indicates that the condition has been relieved and the prognosis is better. Therefore, the test results can serve as a reference indicator for evaluating the long-term prognosis of patients with systemic lupus erythematosus.

5. Distinguishing other autoimmune diseases: Although anti double stranded DNA antibodies have high specificity for systemic lupus erythematosus, in rare cases, low droplet positivity may also occur in patients with other autoimmune diseases such as mixed connective tissue disease and chronic active hepatitis. Therefore, the antibody test results need to be comprehensively judged based on the patient's clinical manifestations, other autoantibody spectra such as anti nuclear antibodies, anti Sm antibodies, and imaging examinations to avoid misdiagnosis.

It is not necessary to fast before performing anti double stranded DNA antibody testing, but it is recommended to inform the doctor of the complete medication history as certain drugs may affect the test results. Maintain a regular daily routine and avoid sun exposure. If diagnosed with systemic lupus erythematosus, it is necessary to follow medical advice for regular check ups and monitor urine routine, kidney function, and other indicators.